Discovery of THB Derivates as Ferroptosis Inhibitors for the Treatment of Acute Kidney Injury by Targeting VDAC
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c00280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Shengkuan Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, China Pharmaceutical University, Nanjing 211198, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Acute Kidney Injury, Voltage-Dependent Anion Channels, Drug Discovery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute kidney injury (AKI), a clinical syndrome marked by high morbidity and mortality, remains a significant challenge due to the lack of effective therapeutic options. The accumulation of Fe2+ and reactive oxygen species (ROS) in injured renal cells, which triggers ferroptosis, play a key driver in the pathogenesis of AKI. In this study, tetrahydroberberine (THB), a natural product, was identified as a ferroptosis inhibitor that targeted the voltage-dependent anion channel (VDAC). Through structural optimization, a series of THB derivatives were developed, among which 34a exhibited about 100-fold enhanced ferroptosis inhibitory activity. Moreover, 34a significantly reduced ROS, Fe2+ and restored glutathione (GSH) below 20 nM. In vivo experiments confirmed that 34a effectively alleviated folic acid-induced AKI, accompanied by a reduction in key kidney injury markers. These results highlight the potential of 12-amino THB derivatives as novel ferroptosis inhibitors and provide promising therapeutic strategies for AKI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Science, China Pharmaceutical University, Nanjing 211198, P. R. China.
- School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, P. R. China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, P. R. China.
- Department of Pharmacy, Youjiang Medical University for Nationalities, Baise 533000, P. R. China.
ORCID-Profile: Yadong Chen, Yu Jiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, S., Zhang, W., Sun, Q., Zhang, W., Chen, Y., Lv, Z., Fang, Z., Wei, X., Lu, T., Chen, G., & Jiao, Y. (2025). Discovery of THB Derivates as Ferroptosis Inhibitors for the Treatment of Acute Kidney Injury by Targeting VDAC. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00280
Vancouver
Peng S, Zhang W, Sun Q, Zhang W, Chen Y, Lv Z, et al. Discovery of THB Derivates as Ferroptosis Inhibitors for the Treatment of Acute Kidney Injury by Targeting VDAC. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00280
BibTeX
@article{Peng2025,
author = {Peng, Shengkuan and Zhang, Wenhao and Sun, Qiaoyi and Zhang, Wenqiang and Chen, Yadong and Lv, Zhicheng and Fang, Zhihang and Wei, Xian and Lu, Tao and Chen, Guo and Jiao, Yu},
title = {Discovery of THB Derivates as Ferroptosis Inhibitors for the Treatment of Acute Kidney Injury by Targeting VDAC},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c00280}
}
EUVIMED